ImmunoCellular Therapeutics Announces Fourth Quarter and Full Year 2017 Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/6/2026

1. MU
2. APTX:CN
3. SPY
4. IQMX
5. EROC
6. MSFT
7. MSTR
8. SEER
9. NVDA
10. TSLA

Go back to ImmunoCellular Therapeutics Announces Fourth Quarter and Full Year 2017 Financial Results

ImmunoCellular Therapeutics (IMUC) Reports Q4 Loss of $1.23/Share

March 13, 2018 4:09 PM EDT

ImmunoCellular Therapeutics (NYSE: IMUC) reported Q4 EPS of ($1.23), versus ($7.89) reported last year.

For earnings history and earnings-related data on ImmunoCellular Therapeutics (IMUC) click here.

... More